Literature DB >> 15154614

Circulating immune complexes among diabetic children.

George Nicoloff1, Alexander Blazhev, Chaika Petrova, Petkana Christova.   

Abstract

Insulin dependent diabetes mellitus (IDDM) is an autoimmune disease associated with the presence of different types of autoantibodies. The presence of these antibodies and the corresponding antigens in the circulation leads to the formation of circulating immune complexes (CIC). CIC are known to persist in the blood for long periods of time. Such CIC following deposition in the small blood vessels have the potential to lead to microangiopathy with debilitating clinical consequences. The aim of our pilot study was to investigate whether a correlation exists between CIC and the development of microvascular complications in diabetic children. Isolation of a new glycoprotein complement inhibition factor (CIF) from the parasitic plant Cuscuta europea seed, which appears to bind specifically to complement component C3 has provided an unique tool for the measurement of immune complexes by means of ELISA-type techniques (CIF-ELISA). We studied the levels of CIC (IgG, IgM and IgA) in 58 diabetic children (mean age 12.28 +/- 4.04 years, diabetes duration 5.3 +/- 3.7 years), 29 of them had vascular complications (group 1) and the other 29 were without vascular complications (group 2). As controls, we studied sera samples from 21 healthy children (mean age 13.54 +/- 4.03 years). Sera from the diabetic patients showed statistically significant higher levels of CIC IgG (p = 0.03) than sera from the control group. In sera from group 1 values of CIC IgG showed statistically significant higher levels than controls (0.720 +/- 0.31 vs. 0.46 +/- 0.045; p = 0.011) Sera from 59% of the patients were positive for CIC IgG, 36% for CIC IgM and 9% for CIC IgA. Among 26 patients with microalbuminuria, sera from 17/26 (65%) were positive for CIC IgG, 8/26 (31%) for CIC IgM and 2/26 (8%) for CIC IgA. CIC IgG correlated with HbAlc (r = 0.51; p = 0.005) and microalbuminuria (r = 0.42, p = 0.033). CIC IgA correlated with age (r = 0.44, p = 0.03). CIC IgM correlated with the duration of diabetes (r = 0.63, p = 0.02). These findings suggest that elevated levels of CIC IgG are associated with the development of early diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15154614      PMCID: PMC2275407          DOI: 10.1080/10446670410001670517

Source DB:  PubMed          Journal:  Clin Dev Immunol        ISSN: 1740-2522


  8 in total

1.  Lymphocytes promote albuminuria, but not renal dysfunction or histological damage in a mouse model of diabetic renal injury.

Authors:  A K H Lim; F Y Ma; D J Nikolic-Paterson; A R Kitching; M C Thomas; G H Tesch
Journal:  Diabetologia       Date:  2010-04-27       Impact factor: 10.122

Review 2.  B cells in type 1 diabetes mellitus and diabetic kidney disease.

Authors:  Mia J Smith; Kimber M Simmons; John C Cambier
Journal:  Nat Rev Nephrol       Date:  2017-10-17       Impact factor: 28.314

3.  High levels of oxidized LDL in circulating immune complexes are associated with increased odds of developing abnormal albuminuria in Type 1 diabetes.

Authors:  Maria F Lopes-Virella; Rickey E Carter; Nathaniel L Baker; John Lachin; Gabriel Virella
Journal:  Nephrol Dial Transplant       Date:  2011-08-19       Impact factor: 5.992

4.  New insights into intra- and intermolecular interactions of immunoglobulins: crystal structure of mouse IgG2b-Fc at 2.1-A resolution.

Authors:  Petr Kolenko; Jan Dohnálek; Jarmila Dusková; Tereza Skálová; Renata Collard; Jindrich Hasek
Journal:  Immunology       Date:  2008-09-06       Impact factor: 7.397

5.  High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetes.

Authors:  Maria F Lopes-Virella; Nathaniel L Baker; Kelly J Hunt; Timothy J Lyons; Alicia J Jenkins; Gabriel Virella
Journal:  Diabetes Care       Date:  2012-04-17       Impact factor: 19.112

Review 6.  Role of the adaptive immune system in diabetic kidney disease.

Authors:  Lingyun Kong; Sofianos Andrikopoulos; Richard J MacIsaac; Laura K Mackay; David J Nikolic-Paterson; Niloufar Torkamani; Neda Zafari; Evelyn C S Marin; Elif I Ekinci
Journal:  J Diabetes Investig       Date:  2021-12-21       Impact factor: 4.232

7.  Serum Anti-Collagen IV IgM and IgG Antibodies as Indicators of Low Vascular Turnover of Collagen IV in Patients with Long-Term Complications of Type 2 Diabetes.

Authors:  Krasimir Kostov; Alexander Blazhev
Journal:  Diagnostics (Basel)       Date:  2021-05-19

Review 8.  Circulating Biomarkers of Diabetic Retinopathy: An Overview Based on Physiopathology.

Authors:  Olga Simó-Servat; Rafael Simó; Cristina Hernández
Journal:  J Diabetes Res       Date:  2016-06-08       Impact factor: 4.011

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.